Dualitybio's Next-Generation Her3 Adc Db-1310 Granted FDA Fast Track Designation

RefinitivLess than 1 min read

Duality Biotherapeutics Inc 9606:

DUALITYBIO'S NEXT-GENERATION HER3 ADC DB-1310 GRANTED FDA FAST TRACK DESIGNATION

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Login or create a forever free account to read this news